Skip to main content
PMC home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1997 Jul;179(13):4311–4318. doi: 10.1128/jb.179.13.4311-4318.1997

epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.

M Sugai 1, T Fujiwara 1, K Ohta 1, H Komatsuzawa 1, M Ohara 1, H Suginaka 1
PMCID: PMC179255  PMID: 9209049

Abstract

Staphylococcus capitis EPK1 produces a glycylglycine endopeptidase, ALE-1 (M. Sugai, T. Fujiwara, T. Akiyama, M. Ohara, H. Komatsuzawa, S. Inoue, and H. Suginaka, J. Bacteriol. 179:1193-1202, 1997), which hydrolyzes interpeptide pentaglycine chains of cell wall peptidoglycan of S. aureus. Characterizations of the enzyme activity and cloning of ale-1 revealed that ALE-1 is very similar to prolysostaphin produced by S. simulans bv. staphylolyticus. Strain EPK1 is resistant to lysis by ALE-1 and by lysostaphin. A gene that renders the cells resistant to glycylglycine endopeptidase (epr) was found 322 bp upstream of and in the opposite orientation to ale-1. The deduced amino acid sequence of epr showed similarities to FemA and FemB, which have been characterized as factors essential for methicillin resistance of S. aureus. Inactivation of either femA or femB causes decreased resistance to methicillin, increased resistance to lysostaphin, and decreased glycine content in the interpeptide chains of peptidoglycan. Therefore, femAB is suggested to be involved in the addition of glycine to pentapeptide peptidoglycan precursor. S. aureus with epr on a multicopy plasmid had phenotypes similar to those of femAB mutants except that it did not alter resistance level to methicillin. These results suggest that epr and femAB belong to the protein family involved in adding amino acids to the pentapeptide peptidoglycan precursor and that epr is involved in the addition of serine to the pentapeptide.

Full Text

The Full Text of this article is available as a PDF (614.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Araki Y., Nakatani T., Nakayama K., Ito E. Occurrence of N-nonsubstituted glucosamine residues in peptidoglycan of lysozyme-resistant cell walls from Bacillus cereus. J Biol Chem. 1972 Oct 10;247(19):6312–6322. [PubMed] [Google Scholar]
  2. Asheshov E. H., Winkler K. C. Staphylococcus aureus strains in the "52, 52A, 80, 81 complex". Nature. 1966 Feb 5;209(5023):638–639. doi: 10.1038/209638b0. [DOI] [PubMed] [Google Scholar]
  3. Berger-Bächi B., Barberis-Maino L., Strässle A., Kayser F. H. FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization. Mol Gen Genet. 1989 Oct;219(1-2):263–269. doi: 10.1007/BF00261186. [DOI] [PubMed] [Google Scholar]
  4. Bierbaum G., Sahl H. G. Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J Bacteriol. 1987 Dec;169(12):5452–5458. doi: 10.1128/jb.169.12.5452-5458.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Billot-Klein D., Gutmann L., Bryant D., Bell D., Van Heijenoort J., Grewal J., Shlaes D. M. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics. J Bacteriol. 1996 Aug;178(15):4696–4703. doi: 10.1128/jb.178.15.4696-4703.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clarke A. J. Extent of peptidoglycan O acetylation in the tribe Proteeae. J Bacteriol. 1993 Jul;175(14):4550–4553. doi: 10.1128/jb.175.14.4550-4553.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cleveland R. F., Holtje J. V., Wicken A. J., Tomasz A., Daneo-Moore L., Shockman G. D. Inhibition of bacterial wall lysins by lipoteichoic acids and related compounds. Biochem Biophys Res Commun. 1975 Dec 1;67(3):1128–1135. doi: 10.1016/0006-291x(75)90791-3. [DOI] [PubMed] [Google Scholar]
  8. DeHart H. P., Heath H. E., Heath L. S., LeBlanc P. A., Sloan G. L. The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus. Appl Environ Microbiol. 1995 Apr;61(4):1475–1479. doi: 10.1128/aem.61.4.1475-1479.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dupont C., Clarke A. J. Dependence of lysozyme-catalysed solubilization of Proteus mirabilis peptidoglycan on the extent of O-acetylation. Eur J Biochem. 1991 Feb 14;195(3):763–769. doi: 10.1111/j.1432-1033.1991.tb15764.x. [DOI] [PubMed] [Google Scholar]
  10. Fischer W., Rösel P., Koch H. U. Effect of alanine ester substitution and other structural features of lipoteichoic acids on their inhibitory activity against autolysins of Staphylococcus aureus. J Bacteriol. 1981 May;146(2):467–475. doi: 10.1128/jb.146.2.467-475.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Giudicelli S., Tomasz A. Attachment of pneumococcal autolysin to wall teichoic acids, an essential step in enzymatic wall degradation. J Bacteriol. 1984 Jun;158(3):1188–1190. doi: 10.1128/jb.158.3.1188-1190.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hayashi H., Araki Y., Ito E. Occurrence of glucosamine residues with free amino groups in cell wall peptidoglycan from bacilli as a factor responsible for resistance to lysozyme. J Bacteriol. 1973 Feb;113(2):592–598. doi: 10.1128/jb.113.2.592-598.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Heath H. E., Heath L. S., Nitterauer J. D., Rose K. E., Sloan G. L. Plasmid-encoded lysostaphin endopeptidase resistance of Staphylococcus simulans biovar staphylolyticus. Biochem Biophys Res Commun. 1989 May 15;160(3):1106–1109. doi: 10.1016/s0006-291x(89)80117-2. [DOI] [PubMed] [Google Scholar]
  14. Henikoff S. Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene. 1984 Jun;28(3):351–359. doi: 10.1016/0378-1119(84)90153-7. [DOI] [PubMed] [Google Scholar]
  15. Henze U., Sidow T., Wecke J., Labischinski H., Berger-Bächi B. Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus. J Bacteriol. 1993 Mar;175(6):1612–1620. doi: 10.1128/jb.175.6.1612-1620.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Herbold D. R., Glaser L. Interaction of N-acetylmuramic acid L-alanine amidase with cell wall polymers. J Biol Chem. 1975 Sep 25;250(18):7231–7238. [PubMed] [Google Scholar]
  17. Höltje J. V., Tomasz A. Lipoteichoic acid: a specific inhibitor of autolysin activity in Pneumococcus. Proc Natl Acad Sci U S A. 1975 May;72(5):1690–1694. doi: 10.1073/pnas.72.5.1690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Iversen O. J., Grov A. Studies on lysostaphin. Separation and characterization of three enzymes. Eur J Biochem. 1973 Oct 5;38(2):293–300. doi: 10.1111/j.1432-1033.1973.tb03061.x. [DOI] [PubMed] [Google Scholar]
  19. Kamiryo T., Matsuhashi M. The biosynthesis of the cross-linking peptides in the cell wall peptidoglycan of Staphylococcus aureus. J Biol Chem. 1972 Oct 10;247(19):6306–6311. [PubMed] [Google Scholar]
  20. Komatsuzawa H., Sugai M., Shirai C., Suzuki J., Hiramatsu K., Suginaka H. Triton X-100 alters the resistance level of methicillin-resistant Staphylococcus aureus to oxacillin. FEMS Microbiol Lett. 1995 Dec 15;134(2-3):209–212. doi: 10.1111/j.1574-6968.1995.tb07939.x. [DOI] [PubMed] [Google Scholar]
  21. Komatsuzawa H., Suzuki J., Sugai M., Miyake Y., Suginaka H. The effect of Triton X-100 on the in-vitro susceptibility of methicillin-resistant Staphylococcus aureus to oxacillin. J Antimicrob Chemother. 1994 Dec;34(6):885–897. doi: 10.1093/jac/34.6.885. [DOI] [PubMed] [Google Scholar]
  22. Kopp U., Roos M., Wecke J., Labischinski H. Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target? Microb Drug Resist. 1996 Spring;2(1):29–41. doi: 10.1089/mdr.1996.2.29. [DOI] [PubMed] [Google Scholar]
  23. Kornblum J., Hartman B. J., Novick R. P., Tomasz A. Conversion of a homogeneously methicillin-resistant strain of Staphylococcus aureus to heterogeneous resistance by Tn551-mediated insertional inactivation. Eur J Clin Microbiol. 1986 Dec;5(6):714–718. doi: 10.1007/BF02013311. [DOI] [PubMed] [Google Scholar]
  24. Leclerc D., Asselin A. Detection of bacterial cell wall hydrolases after denaturing polyacrylamide gel electrophoresis. Can J Microbiol. 1989 Aug;35(8):749–753. doi: 10.1139/m89-125. [DOI] [PubMed] [Google Scholar]
  25. Logardt I. M., Neujahr H. Y. Lysis of modified walls from Lactobacillus fermentum. J Bacteriol. 1975 Oct;124(1):73–77. doi: 10.1128/jb.124.1.73-77.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Maidhof H., Reinicke B., Blümel P., Berger-Bächi B., Labischinski H. femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. J Bacteriol. 1991 Jun;173(11):3507–3513. doi: 10.1128/jb.173.11.3507-3513.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Petit J. F., Strominger J. L., Söll D. Biosynthesis of the peptidoglycan of bacterial cell walls. VII. Incorporation of serine and glycine into interpeptide bridges in Staphylococcus epidermidis. J Biol Chem. 1968 Feb 25;243(4):757–767. [PubMed] [Google Scholar]
  28. Recsei P. A., Gruss A. D., Novick R. P. Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1127–1131. doi: 10.1073/pnas.84.5.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Robinson J. M., Hardman J. K., Sloan G. L. Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus. J Bacteriol. 1979 Mar;137(3):1158–1164. doi: 10.1128/jb.137.3.1158-1164.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Robson R. L., Baddiley J. Role of teichuronic acid in Bacillus licheniformis: defective autolysis due to deficiency of teichuronic acid in a novobiocin-resistant mutant. J Bacteriol. 1977 Feb;129(2):1051–1058. doi: 10.1128/jb.129.2.1051-1058.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rosenthal R. S., Blundell J. K., Perkins H. R. Strain-related differences in lysozyme sensitivity and extent of O-acetylation of gonococcal peptidoglycan. Infect Immun. 1982 Aug;37(2):826–829. doi: 10.1128/iai.37.2.826-829.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ryffel C., Strässle A., Kayser F. H., Berger-Bächi B. Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1994 Apr;38(4):724–728. doi: 10.1128/aac.38.4.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. SCHINDLER C. A., SCHUHARDT V. T. LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS. Proc Natl Acad Sci U S A. 1964 Mar;51:414–421. doi: 10.1073/pnas.51.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. SCHINDLER C. A., SCHUHARDT V. T. PURIFICATION AND PROPERTIES OF LYSOSTAPHIN--A LYTIC AGENT FOR STAPHYLOCOCCUS AUREUS. Biochim Biophys Acta. 1965 Feb 15;97:242–250. doi: 10.1016/0304-4165(65)90088-7. [DOI] [PubMed] [Google Scholar]
  35. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Schleifer K. H., Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev. 1972 Dec;36(4):407–477. doi: 10.1128/br.36.4.407-477.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Skinner S., Inglis B., Matthews P. R., Stewart P. R. Mercury and tetracycline resistance genes and flanking repeats associated with methicillin resistance on the chromosome of Staphylococcus aureus. Mol Microbiol. 1988 Mar;2(2):289–292. doi: 10.1111/j.1365-2958.1988.tb00030.x. [DOI] [PubMed] [Google Scholar]
  38. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  39. Stewart P. R., Waldron H. G., Lee J. S., Matthews P. R. Molecular relationships among serogroup B bacteriophages of Staphylococcus aureus. J Virol. 1985 Jul;55(1):111–116. doi: 10.1128/jvi.55.1.111-116.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Strandén A. M., Ehlert K., Labischinski H., Berger-Bächi B. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J Bacteriol. 1997 Jan;179(1):9–16. doi: 10.1128/jb.179.1.9-16.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sugai M., Akiyama T., Komatsuzawa H., Miyake Y., Suginaka H. Characterization of sodium dodecyl sulfate-stable Staphylococcus aureus bacteriolytic enzymes by polyacrylamide gel electrophoresis. J Bacteriol. 1990 Nov;172(11):6494–6498. doi: 10.1128/jb.172.11.6494-6498.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sugai M., Fujiwara T., Akiyama T., Ohara M., Komatsuzawa H., Inoue S., Suginaka H. Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1. J Bacteriol. 1997 Feb;179(4):1193–1202. doi: 10.1128/jb.179.4.1193-1202.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sugai M., Koike H., Hong Y. M., Miyake Y., Nogami R., Suginaka H. Purification of a 51 kDa endo-beta-N-acetylglucosaminidase from Staphylococcus aureus. FEMS Microbiol Lett. 1989 Oct 15;52(3):267–272. doi: 10.1016/0378-1097(89)90209-7. [DOI] [PubMed] [Google Scholar]
  44. Sugai M., Komatsuzawa H., Akiyama T., Hong Y. M., Oshida T., Miyake Y., Yamaguchi T., Suginaka H. Identification of endo-beta-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase as cluster-dispersing enzymes in Staphylococcus aureus. J Bacteriol. 1995 Mar;177(6):1491–1496. doi: 10.1128/jb.177.6.1491-1496.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sugai M., Komatsuzawa H., Ooku-Inomata K., Miyake Y., Ishida E., Suginaka H. Isolation and characterization of Staphylococcus aureus mutants which form altered cell clusters. Microbiol Immunol. 1994;38(12):995–999. doi: 10.1111/j.1348-0421.1994.tb02158.x. [DOI] [PubMed] [Google Scholar]
  46. Swim S. C., Gfell M. A., Wilde C. E., 3rd, Rosenthal R. S. Strain distribution in extents of lysozyme resistance and O-acetylation of gonococcal peptidoglycan determined by high-performance liquid chromatography. Infect Immun. 1983 Nov;42(2):446–452. doi: 10.1128/iai.42.2.446-452.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Thorndike J., Park J. T. A method for demonstrating the stepwise addition of glycine from transfer RNA into the murein precursor of Staphylococcus aureus. Biochem Biophys Res Commun. 1969 Jun 6;35(5):642–647. doi: 10.1016/0006-291x(69)90452-5. [DOI] [PubMed] [Google Scholar]
  48. Thumm G., Götz F. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus. Mol Microbiol. 1997 Mar;23(6):1251–1265. doi: 10.1046/j.1365-2958.1997.2911657.x. [DOI] [PubMed] [Google Scholar]
  49. Tipper D. J. Structures of the cell wall peptidoglycans of Staphylococcus epidermidis Texas 26 and Staphylococcus aureus Copenhagen. II. Structure of neutral and basic peptides from hydrolysis with the Myxobacter al-1 peptidase. Biochemistry. 1969 May;8(5):2192–2202. doi: 10.1021/bi00833a061. [DOI] [PubMed] [Google Scholar]
  50. Tomasz A., Westphal M., Briles E. B., Fletcher P. On the physiological functions of teichoic acids. J Supramol Struct. 1975;3(1):1–16. doi: 10.1002/jss.400030102. [DOI] [PubMed] [Google Scholar]
  51. Yanisch-Perron C., Vieira J., Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene. 1985;33(1):103–119. doi: 10.1016/0378-1119(85)90120-9. [DOI] [PubMed] [Google Scholar]
  52. Zygmunt W. A., Browder H. P., Tavormina P. A. Susceptibility of coagulase-negative staphylococci to lysostaphin and other antibiotics. Appl Microbiol. 1968 Aug;16(8):1168–1173. doi: 10.1128/am.16.8.1168-1173.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Zygmunt W. A., Tavormina P. A. Lysostaphin: model for a specific enzymatic approach to infectious disease. Prog Drug Res. 1972;16:309–333. doi: 10.1007/978-3-0348-7081-8_7. [DOI] [PubMed] [Google Scholar]
  54. de Jonge B. L., Chang Y. S., Gage D., Tomasz A. Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin binding protein 2A. J Biol Chem. 1992 Jun 5;267(16):11248–11254. [PubMed] [Google Scholar]
  55. de Jonge B. L., Sidow T., Chang Y. S., Labischinski H., Berger-Bachi B., Gage D. A., Tomasz A. Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus. J Bacteriol. 1993 May;175(9):2779–2782. doi: 10.1128/jb.175.9.2779-2782.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES